ArticleJournal of the American Heart Association2025
New-Onset Atrial Fibrillation During ST-Segment-Elevation Myocardial Infarction: Risk of Recurrence and Its Clinical Impact During 10 Years of Follow-Up.
Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The role of stress hyperglycemia in in-hospital new-onset atrial fibrillation among patients with acute myocardial infarction: a narrative review.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtrial fibrillation (AF) often complicates ST-segment-elevation myocardial infarction (STEMI), but data on AF recurrence after first-ever AF during STEMI are scarce. We aimed at assessing the risk of AF recurrence after first-ever transient AF during admission for STEMI.
methodsWe performed a single-center, register-based cohort study. Patients with STEMI discharged alive after primary percutaneous coronary intervention during 2007 to 2010 were followed until 2018. Clinical characteristics, date of AF diagnosis, and mortality status were retrieved from Swedish national registries. All ECGs recorded before, during, or after STEMI were reviewed. The primary end point was the first documented AF episode after discharge, and the secondary end point was mortality. The risk of AF during follow-up was calculated using the Fine-Gray subdistributional hazard model for AF and total mortality, regressed on prespecified clinical and demographic covariates. In patients with first-ever transient AF during STEMI, we looked for the factors associated with AF recurrence.
resultsOf 2120 patients discharged alive, 127 (5.9%) had AF during admission for STEMI. Patients with AF during STEMI were more likely to develop AF during follow-up (hazard ratio [HR], 4.82 [95% CI, 3.86-6.02];
conclusionsTransient AF during STEMI is associated with an increased risk of AF after discharge and long-term mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.